D.J. Nutt

3.1k total citations · 1 hit paper
47 papers, 2.2k citations indexed

About

D.J. Nutt is a scholar working on Cellular and Molecular Neuroscience, Experimental and Cognitive Psychology and Cognitive Neuroscience. According to data from OpenAlex, D.J. Nutt has authored 47 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 13 papers in Experimental and Cognitive Psychology and 11 papers in Cognitive Neuroscience. Recurrent topics in D.J. Nutt's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Psychedelics and Drug Studies (7 papers). D.J. Nutt is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Psychedelics and Drug Studies (7 papers). D.J. Nutt collaborates with scholars based in United Kingdom, United States and Belgium. D.J. Nutt's co-authors include David Erritzøe, Mendel Kaelen, Amanda Feilding, Robin Carhart‐Harris, Robin Carhart‐Harris, Mark Bolstridge, S. Clare Stanford, James Rucker, Stephen Pilling and Michael Bloomfield and has published in prestigious journals such as Neuroscience, Neuroscience & Biobehavioral Reviews and The British Journal of Psychiatry.

In The Last Decade

D.J. Nutt

44 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

2017 646 citations Robin Carhart‐Harris, Mark Bolstridge et al. Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.J. Nutt United Kingdom	21	1.4k	826	679	339	301	47	2.2k
Claire Wilcox United States	17	972 0.7×	637 0.8×	505 0.7×	222 0.7×	159 0.5×	40	1.9k
Laurence Reed United Kingdom	22	820 0.6×	842 1.0×	302 0.4×	456 1.3×	306 1.0×	42	3.0k
Torsten Passie Germany	24	2.1k 1.5×	1.1k 1.3×	1.1k 1.6×	116 0.3×	470 1.6×	50	2.7k
U. McCann United States	14	1.3k 1.0×	795 1.0×	494 0.7×	93 0.3×	373 1.2×	17	1.9k
Erich Studerus Switzerland	27	1.5k 1.1×	783 0.9×	611 0.9×	383 1.1×	229 0.8×	76	2.9k
Valerie H. Curran United Kingdom	10	1.1k 0.8×	765 0.9×	600 0.9×	116 0.3×	639 2.1×	15	1.9k
Rafael Faria Sanches Brazil	15	1.2k 0.9×	556 0.7×	403 0.6×	105 0.3×	496 1.6×	25	1.7k
Dea Siggaard Stenbæk Denmark	20	952 0.7×	573 0.7×	512 0.8×	136 0.4×	145 0.5×	81	1.6k
Patrick C. Dolder Switzerland	27	2.0k 1.5×	1.3k 1.5×	1.1k 1.6×	96 0.3×	189 0.6×	43	2.5k
Andrea L. Malizia United Kingdom	22	1.2k 0.9×	1.1k 1.3×	313 0.5×	771 2.3×	616 2.0×	56	3.5k

Countries citing papers authored by D.J. Nutt

Since Specialization

Citations

This map shows the geographic impact of D.J. Nutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. Nutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. Nutt more than expected).

Fields of papers citing papers by D.J. Nutt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. Nutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. Nutt. The network helps show where D.J. Nutt may publish in the future.

Co-authorship network of co-authors of D.J. Nutt

This figure shows the co-authorship network connecting the top 25 collaborators of D.J. Nutt. A scholar is included among the top collaborators of D.J. Nutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.J. Nutt. D.J. Nutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doble, Adam, Ian L. Martin, & D.J. Nutt. (2020). Calming the Brain: Benzodiazepines and related drugs from laboratory to clinic.

Carhart‐Harris, Robin, Mark Bolstridge, Camilla Day, et al.. (2017). Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. 235(2). 399–408. 646 indexed citations breakdown →

Turton, Samuel, D.J. Nutt, & Robin Carhart‐Harris. (2015). A Qualitative Report on the Subjective Experience of Intravenous Psilocybin Administered in an fMRI Environment. Current Drug Abuse Reviews. 7(2). 117–127. 43 indexed citations

Carhart‐Harris, Robin, Robert Leech, Tom A. Williams, et al.. (2012). Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. The British Journal of Psychiatry. 200(3). 238–244. 159 indexed citations

Tyacke, Robin J., et al.. (2009). P.l.c.044 Paradoxical effects of GABA on the in vivo uptake of the partial inverse GABA agonist [3H]Ro15-4513 in rat brain. European Neuropsychopharmacology. 19. S276–S277.

Williams, Theresa M., et al.. (2008). P.6.c.008 Can personality traits elucidate the relationship between substance dependence and opioid receptor availability?. European Neuropsychopharmacology. 18. S536–S536. 1 indexed citations

Bailey, Jayne, A. Papadopoulos, Anne Lingford‐Hughes, & D.J. Nutt. (2007). d-Cycloserine and performance under different states of anxiety in healthy volunteers. Psychopharmacology. 193(4). 579–585. 30 indexed citations

Argyropoulos, S., Sean Hood, Simon Davies, et al.. (2006). S.15.04 Dopaminergic challenges in social anxiety disorder. European Neuropsychopharmacology. 16. S186–S186. 1 indexed citations

Lingford‐Hughes, Anne, Steven James Wilson, V J Cunningham, et al.. (2005). GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study. Psychopharmacology. 180(4). 595–606. 38 indexed citations

10.

Potokar, John, et al.. (2004). Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia. International Clinical Psychopharmacology. 19(2). 77–84. 13 indexed citations

11.

Hudson, Alan L., et al.. (2004). Animal Models for Obsessive-Compulsive Disorder. Current Neuropharmacology. 2(2). 169–181. 24 indexed citations

12.

Daglish, Mark, Jan Melichar, Anne Lingford‐Hughes, et al.. (2000). C-11-diprenorphine PET imaging of opioid binding during chronic methadone treatment and early abstinence. Queensland's institutional digital repository (The University of Queensland). 41(5). 1 indexed citations

13.

Ballenger, J.C., J R Davidson, Y. Lecrubier, et al.. (2000). Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety.. PubMed. 61 Suppl 5. 60–6. 234 indexed citations

14.

Nutt, D.J.. (1998). Efficacy of mirtazapine in clinically relevant subgroups of depressed patients. Depression and Anxiety. 7(S1). 7–10. 9 indexed citations

15.

Dalley, Jeff, Christine A. Parker, Ernst Wülfert, Alan L. Hudson, & D.J. Nutt. (1998). Potentiation of barbiturate‐induced alterations in presynaptic noradrenergic function in rat frontal cortex by imidazol(in)e α₂‐adrenoceptor agonists. British Journal of Pharmacology. 125(3). 441–446. 14 indexed citations

16.

Bailey, Jayne, et al.. (1997). The feasibility of abrupt methadone‐buprenorphine transfer in British opiate addicts in an outpatient setting. Addiction Biology. 2(2). 191–200. 24 indexed citations

17.

Argyropoulos, S. & D.J. Nutt. (1997). Anhedonia and chronic mild stress model in depression. Psychopharmacology. 134(4). 333–336. 19 indexed citations

18.

Tolchard, Stephen, et al.. (1996). TNFα mimics the endocrine but not the thermoregulatory responses of bacterial lipopolysaccharide (LPS): Correlation with FOS-expression in the brain. Neuropharmacology. 35(3). 243–248. 16 indexed citations

19.

Smith, Jeffery A., K. Williams, Sonia D. Birkett, et al.. (1994). Neuroendocrine and clinical effects of electroconvulsive therapy and their relationship to treatment outcome. Psychological Medicine. 24(3). 547–555. 15 indexed citations

20.

Jackson, Helen C. & D.J. Nutt. (1993). Investigation of the involvement of opioid receptors in the action of anticonvulsants. Psychopharmacology. 111(4). 486–490. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact